Biotechnology·Finance·Investing·News The Astonishing 945% Surge: Is Monopar Therapeutics’ Cash Strategy the Key to Its Success? Monopar Therapeutics experienced a remarkable 945% surge in share price over the past year, attributed to strategic cash management rather than revenue by Marques Jivaro 17 hours ago
Starting Over at 42: How a Single Parent is Turning Financial Angst into a Strategic Opportunity 1 hour ago
A Tumultuous Day in Global Markets: Trump’s Tariff Rollercoaster Sends Shockwaves Worldwide 4 hours ago
Il Picco Elettrico: Rivian Cavalca Alto grazie a Mosse Strategiche e ai Problemi di Tesla Nisan 2, 2025